Short Interest in Valhi, Inc. (NYSE:VHI) Grows By 24.3%

Short interest in Valhi, Inc. (NYSE:VHI) significantly increased by 24.3% in March to 67,454 shares, representing a 3.1-day ratio of short interest and about 0.2% of the company's shares sold short. This rise comes after Valhi reported a substantial quarterly earnings miss, posting an EPS of ($1.86) against a $0.86 consensus, alongside negative net margin and return on equity. The company declared a $0.08 quarterly dividend, while analysts maintain a consensus "Sell" rating with a $12 price target, contrasting with the current trading price around $14.22.

Original reporting
MarketBeat · MarketBeat
Published Mar 31, 2026, 5:09 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Mar 31, 2026, 5:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Short Interest in Valhi, Inc. (NYSE:VHI) Grows By 24.3% — source image
Decision brief

The 30-second read

$VHIBearishHigh
01

Why it matters

The rise in short interest and earnings disappointment suggest a cautious or bearish outlook among investors.

02

Market read

The news has high relevance for traders holding or considering trading VHI, indicating potential downward pressure.

03

What to watch

Potential for a short squeeze if short interest declines or if positive news emerges; macroeconomic factors could also influence the stock.

Relevance 6/10Timing: Immediate; news published within the last 24 hours.

Background

Valhi, Inc. reported a significant earnings miss in the latest quarter, leading to increased short interest and bearish sentiment.

Company-level read

Ticker impact

$VHIBearishHigh confidence
Context

High relevance due to significant short interest increase and earnings miss.

Expected impact

Potential short-term decline of 5-10% in stock price.

Evidence & confidence

The combination of a 24.3% increase in short interest, earnings miss, and bearish analyst ratings indicates a strong bearish outlook.

Market effects

Negative sentiment may pressure the broader industrial or manufacturing sectors if Valhi is representative.

Limited; specific to US markets.

Minimal; company-specific news.

Counterpoint

The earnings miss may be a short-term anomaly; the stock could rebound if the company issues positive guidance or if short covering occurs.

Key entities

  • Valhi, Inc.

    A diversified holding company with interests in various sectors.

Related articles

$VHIHigh

VALHI REPORTS THIRD QUARTER 2026 RESULTS

VALHI INC /DE/ (VHI) filed an SEC Form 8-K — Results of Operations and Financial Condition. ‌ ​ ​ ​ ‌ ​ ​ ​ ​ VALHI REPORTS THIRD QUARTER 2026 RESULTS ​ DALLAS, TEXAS . . November 5, 2026. Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $30.2 million, or $1.06 per share, in the third quarter of 2026 compared to a net loss of $22.2 milli

$VHIMed

VALHI REPORTS SECOND QUARTER 2026 RESULTS

VALHI INC /DE/ (VHI) filed an SEC Form 8-K — Results of Operations and Financial Condition. ‌ ​ ​ ​ ‌ ​ ​ ​ ​ VALHI REPORTS SECOND QUARTER 2026 RESULTS ​ DALLAS, TEXAS . . August 6, 2026. Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $22.3 million, or $.78 per share, in the second quarter of 2026 compared to net income of $.9 million,

$VKTXMed

Viking Therapeutics Highlights Clinical Data from VK2735 Obesity Program at ObesityWeek® 2026

Viking Therapeutics (VKTX) presented clinical data from its VK2735 obesity program at ObesityWeek 2026. In a Phase 2 trial, 74% of participants improved by at least one BMI category after 13 weeks, with significant reductions in cardiometabolic markers. The company also shared baseline data from its ongoing Phase 3 VANQUISH-2 study. VK2735 is a dual GLP-1 and GIP receptor agonist being developed for obesity and metabolic disorders.

$NVDAHigh

Jensen Huang steps down as Nvidia chief and the hunt for a new CEO begins

Nvidia announced CEO Jensen Huang's resignation and departure from the board. Colette Kress, the CFO, is interim CEO. The company thanked Huang for his contributions. No reason was given, but speculation links it to his personal scandal and national security concerns. The FBI is investigating alleged Nvidia chip exports to China via Megaspeed, where Alice Huang, tied to Jensen, is an executive. This could impact US-China relations and AI competition.

$NVDAHigh

The rise and fall of Jensen Huang

Nvidia's CEO Jensen Huang resigned after admitting an affair, with shares dropping 40% from October's peak. The board named CFO Colette Kress as interim CEO. Huang's exit raises concerns about Nvidia's key man risk and potential regulatory scrutiny, especially regarding US-China AI rivalry. The company's stock fell to $148.80 before recovering to $162.85.